Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-039686

KYNTRA BIO, INC. · KYNB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jun 9, 2017
Accepted (ET)
Jun 13, 2017 · 7:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJun 9, 2017M12,000$3.50A60,000D
Common StockJun 9, 2017M3,000$5.95A63,000D
Common StockF1Jun 9, 2017S15,000$29.20D48,000D
Common StockJun 12, 2017M3,000$5.95A51,000D
Common StockJun 12, 2017M12,000$9.775A63,000D
Common StockF2Jun 12, 2017S15,000$28.57D48,000D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F3$3.50Jun 9, 2017M12,000D—Mar 15, 2021Common Stock12,0000D
Stock Option (Right to Buy)F3$5.95Jun 9, 2017M3,000D—Jun 27, 2022Common Stock3,0003,000D
Stock Option (Right to Buy)F3$5.95Jun 12, 2017M3,000D—Jun 27, 2022Common Stock3,0000D
Stock Option (Right to Buy)F3$9.775Jun 12, 2017M12,000D—Apr 17, 2023Common Stock12,0000D

Explanation of responses